A newly effective Inflation Reduction Act (IRA) provision is improving prescription drug affordability for many people with Medicare Part D

Last month, the office of the Assistant Secretary for Planning and Evaluation (ASPE), a research arm of the Department of

Last week, the Medicare Rights Center joined with other advocacy organizations to urge a federal court to reject claims by

Last month, the Government Accountability Office (GAO) recommended that the Centers for Medicare & Medicaid Services monitor the effects of

Last week, the Centers for Medicare & Medicaid Services (CMS) announced that all of the manufacturers of the first 10

On Tuesday, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 Medicare Part D drugs that will